The emerging role of miRNAs in combined cancer therapy

Expert Opinion on Biological Therapy

Volumn 15, Issue 7, 2015, Pages 923-925

  Yu, Hong W ^a   Cho, William C ^b  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

Chemotherapy; Combined cancer therapy; Immunotherapy; MicroRNA; Radiotherapy

Indexed keywords

ANTAGOMIR; COMPLEMENTARY RNA; MICRORNA; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CELL TRANSFORMATION; CYTOTOXIC T LYMPHOCYTE; ELECTROPORATION; HUMAN; IMMUNOCOMPETENT CELL; MULTIMODALITY CANCER THERAPY; NEXT GENERATION SEQUENCING; PRIMARY CELL; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; GENE SILENCING; IMMUNOTHERAPY; NEOPLASMS;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; GENE SILENCING; HUMANS; IMMUNOTHERAPY; MICRORNAS; NEOPLASMS;

EID: 84929635695     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2015.1030390     Document Type: Review

References (18)

1. Cho WC. MicroRNAs in cancer-from research to therapy. Biochim Biophys Acta 2010;1805:209-17
2. He X, Li J, Guo W, et al. Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma. Oncotarget 2015;6(4):2302-14
3. Liu Q, Zou R. Zhou R, et al. miR-155 regulates glioma cells invasion and chemosensitivity by p38 isoforms in vitro. J Cell Biochem 2014. [Epub ahead of print]
4. Khan S, Ebeling MC, Zaman MS, et al. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget 2014;5:7599-609
5. Kim SJ, Oh JS, Shin JY, et al. Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 2011;155:427-34
6. Talwar S, House R, Sundaramurthy S, et al. Inhibition of caspases protects mice from radiation-induced oral mucositis and abolishes the cleavage of RNA-binding protein HuR. J Biol Chem 2014;6:3487-500
7. Wang S, Zhang R, Claret FX, et al. Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation. Mol Cancer Ther 2014;13:3163-74
8. Li G, Wang Y, Liu Y, et al. miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro. Cancer Sci 2014;105:1560-8
9. Qu C, Liang Z, Huang J, et al. miR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle 2012;11:785-96
10. Yuan W, Xiaoyun H, Haifeng Q, et al. MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis. Int J Med Sci 2014;11:691-6
11. Yu HW, Sze DM, Cho WC. MicroRNAs involved in anti-tumour immunity. Int J Mol Sci 2013;14:5587-607
12. Yun S, Lee SU, Kim JM, et al. Integrated mRNA-microRNA profiling of human NK cell differentiation identifies miR-583 as a negative regulator of IL2Rg expression. PLoS One 2014;9:e108913
13. Lin R, Chen L, Chen G, et al. Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression. J Clin Invest 2014;124:5352-67
14. D'Angelo E, Vicentini C, Aqostini M, et al. MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis. Curr Drug Targets 2014. [Epub ahead of print]
15. Matuszcak C, Haier J, Hummel R, et al. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. World J Gastroenterol 2014;20:13658-66
16. Kalia M. Biomarkers for personalized oncology: recent advances and future challenges. Metabolism 2015;64(3 Suppl 1):S16-21
17. Wu K, Huang RS, House L, et al. Next-generation sequencing for lung cancer. Future Oncol 2013;9:1323-36
18. Benett NC, Farah CS. Next-generation sequencing in clinical oncology: next steps towards clinical oncology. Cancers (Basel) 2014;6:2296-312